Page 425 - Data Analysis News Today

Data Discovery Market to Set New Growth Story | QlikTech International AB, Tableau Software, Microsoft

Today the fda is expected to grant emergency use authorization to pfizer for its vaccine for kids ages 5 to 11. that means younger kids could get their first shot within days. this is happening as the average number of daily booster shots administered to adults has reached a new high. theres also new data analysis showing the vast majority of vaccinated adults qualify for that extra jab. senior medical correspondent elizabeth cohen joining me now. walk through what were learning in this data. >>...

Are eligible for a booster once of course they pass the appropriate amount of time. so we asked the folks at the comp additional epidemiology lab at childrens hospital to do a data analysis for us. lets look at sort of what they found and what some of the back ground is here. everyone who got zone son and johnson qualifies for a booster as long as they are two months past their shot. pfizer and moderna, if you are six months past your shot, 65 plus, front line worker, underlying medical conditio...

Food industry news, voices and jobs. Optimized for your mobile phone.

The Netherlands Forensic Institute was able to obtain previously unknown information about Tesla's Autopilot system, according to the report.

/PRNewswire/ -- Dynanet successfully renewed the Capability Maturity Model Integration (CMMI)® Maturity Level (ML) 5 rating of its software development...

/PRNewswire/ -- Dynanet successfully renewed the Capability Maturity Model Integration (CMMI)® Maturity Level (ML) 5 rating of its software development...

The Icahn School of Medicine at Mount Sinai is establishing a Skin Biology and Diseases Resource-based Center (SBDRC), funded by a $4 million

Consultancy - E-Learning Programme Effectiveness, New York Organization: UNICEF - United Nations Children’s Fund Country: United States City: New York...

Doses of vaccine going to waste. >> its a potential problem. this is the issue with -- you want to surge these vaccines so you dont run into supply problems. but this is an issue. i think that the numbers may change as we often see in terms of peoples willingness to go ahead and get the vaccine once theres official weigh ins from the fda and cdc. i dont know how much it will budge. and sometimes people wont rush out and get it right away but they may take some time. but hopefully the numbers go ...